Eledon Pharmaceuticals
ELDN
ELDN
30 hedge funds and large institutions have $14.7M invested in Eledon Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
4
Closed
5
Calls
$17K
Puts
$3K
Net Calls
+$14K
Net Calls Change
+$8K
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$72.7K |
2 |
Charles Schwab
San Francisco,
California
|
+$35.4K |
3 |
V
Veritable
Wilmington,
Delaware
|
+$30.7K |
4 |
Millennium Management
New York
|
+$30K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
Top Sellers
1 |
EP
Eversept Partners
New York
|
-$154K |
2 |
SFG
SVB Financial Group
Dallas,
Texas
|
-$32.3K |
3 |
Two Sigma Investments
New York
|
-$9.56K |
4 |
UBS Group
Zurich,
Switzerland
|
-$8.34K |
5 |
Rockefeller Capital Management
New York
|
-$3K |